GR3035991T3 - Procedure for quantifying glycosaminoglycan in antithrombin III containing solutions - Google Patents

Procedure for quantifying glycosaminoglycan in antithrombin III containing solutions

Info

Publication number
GR3035991T3
GR3035991T3 GR20010400844T GR20010400844T GR3035991T3 GR 3035991 T3 GR3035991 T3 GR 3035991T3 GR 20010400844 T GR20010400844 T GR 20010400844T GR 20010400844 T GR20010400844 T GR 20010400844T GR 3035991 T3 GR3035991 T3 GR 3035991T3
Authority
GR
Greece
Prior art keywords
glycosaminoglycan
quantifying
procedure
antithrombin iii
containing solutions
Prior art date
Application number
GR20010400844T
Other languages
English (en)
Inventor
Juergen Dr Roemisch
Harald Stauss
Original Assignee
Centeon Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centeon Pharma Gmbh filed Critical Centeon Pharma Gmbh
Publication of GR3035991T3 publication Critical patent/GR3035991T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/38—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, e.g. Konjac gum, Locust bean gum, Guar gum
    • G01N2400/40—Glycosaminoglycans, i.e. GAG or mucopolysaccharides, e.g. chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparin, heparan sulfate, and related sulfated polysaccharides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
    • Y10T436/255—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.] including use of a solid sorbent, semipermeable membrane, or liquid extraction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
GR20010400844T 1996-08-17 2001-06-06 Procedure for quantifying glycosaminoglycan in antithrombin III containing solutions GR3035991T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19633214 1996-08-17

Publications (1)

Publication Number Publication Date
GR3035991T3 true GR3035991T3 (en) 2001-09-28

Family

ID=7802907

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20010400844T GR3035991T3 (en) 1996-08-17 2001-06-06 Procedure for quantifying glycosaminoglycan in antithrombin III containing solutions

Country Status (12)

Country Link
US (1) US6117647A (el)
EP (1) EP0825443B1 (el)
JP (1) JPH1090273A (el)
KR (1) KR100452014B1 (el)
AT (1) ATE200580T1 (el)
AU (1) AU715808B2 (el)
CA (1) CA2213166A1 (el)
DE (1) DE59703340D1 (el)
DK (1) DK0825443T3 (el)
ES (1) ES2155954T3 (el)
GR (1) GR3035991T3 (el)
PT (1) PT825443E (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8232073B2 (en) 2009-01-02 2012-07-31 Zacharon Pharmaceuticals, Inc. Quantification of non-reducing end glycan residual compounds
US8183003B2 (en) 2009-01-02 2012-05-22 Zacharon Pharmaceuticals, Inc. Polymer end group detection
US9029530B2 (en) * 2009-01-02 2015-05-12 Biomarin Pharmaceutical Inc. Detection of oligosaccharides
US8809009B2 (en) 2009-01-02 2014-08-19 Biomarin Pharmaceutical Inc. Methods of diagnosing a disease and methods of monitoring treatment of a disease by quantifying a non-reducing end glycan residual compound and comparing to a second biomarker

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0217768B1 (en) * 1985-09-05 1991-06-12 E. Thye Yin Method and compositions for heparin assays
GB8913183D0 (en) * 1989-06-08 1989-07-26 Central Blood Lab Authority Chemical products
US5320945A (en) * 1989-07-14 1994-06-14 Boehringer Mannheim Gmbh Method and reagent for the determination of antithrombin III
DE3923340A1 (de) * 1989-07-14 1991-01-24 Boehringer Mannheim Gmbh Verfahren und reagenz zur bestimmung von antithrombin iii
JPH0694713A (ja) * 1991-07-31 1994-04-08 Masashi Funayama アンチトロンビンｉｉｉ活性の測定方法とそれを用いたアンチトロンビンｉｉｉ活性の測定キット
JPH078298A (ja) * 1993-06-28 1995-01-13 Nippon Shoji Kk アンチトロンビンｉｉｉ活性の測定方法および該測定用試薬キット

Also Published As

Publication number Publication date
EP0825443A1 (de) 1998-02-25
AU3419697A (en) 1998-02-26
ATE200580T1 (de) 2001-04-15
EP0825443B1 (de) 2001-04-11
PT825443E (pt) 2001-08-30
DE59703340D1 (de) 2001-05-17
AU715808B2 (en) 2000-02-10
KR19980018719A (ko) 1998-06-05
US6117647A (en) 2000-09-12
KR100452014B1 (ko) 2004-11-20
CA2213166A1 (en) 1998-02-17
JPH1090273A (ja) 1998-04-10
DK0825443T3 (da) 2001-08-06
ES2155954T3 (es) 2001-06-01

Similar Documents

Publication Publication Date Title
EP0653068A4 (en) BIOSENSOR FOR HEMATOCRIT DETECTION.
PL323873A1 (en) System for measuring oxygen content in blood
EP0599812A3 (en) Raw material made of cellulose, non-combustible, bulky layers produced and method for producing the layers.
EP0667524A3 (en) Electrochemical measurement of the oxygen content.
DE3886452T2 (de) Schichtmittel für Kohlenstoffasern.
NO904838D0 (no) Fremgangsmaate for aa fjerne sulfationer fra vandige alkalimetallkloridloesninger.
EP0611965A3 (en) Carbon analyzer for both aqueous solutions and solid samples.
GR3035991T3 (en) Procedure for quantifying glycosaminoglycan in antithrombin III containing solutions
EP0623819A3 (en) Device for determining the concentration of various ions in aqueous solutions.
AU6242790A (en) Method for determination of ion concentration, specific gravity, or osmotic pressure of solution and apparatus therefor
AU1997788A (en) Filtration unit, in particular for medical specimens
AU5704398A (en) Treatment process for cellulosic fibers
GB2278315B (en) Chambered doctor blade unit
NO900088L (no) Fremgangsmaate ved bestemmelse av den fibrinolytiske totalaktivitet i plasma.
AU4679097A (en) Process for regenerating sodium sulphide from the sodium sulphate which forms in treating lead past from exhausted batteries
DE69014806D1 (de) Evakuierungsverfahren für Behälter radioaktiven Abfalls.
EP0473087A3 (en) Process for reducing the concentration in solution of a particular ion or a particular group of ions
AU6468299A (en) Method for determining alkaline phosphatase and eliminating haemoglobin disturbances
AU3239084A (en) Process for removing lipoproteins from aqueous solutions using derivatized polyhydroxymethylene
EP0685589A3 (de) Verfahren zur Vorbehandlung natürlicher Fasern.
ITRM930634A0 (it) Complessi monoazoici del rame reattivi verso le fibre. (caso 150-5653)
DK0379239T3 (da) Fremgangsmåde til fraspaltning af delta4-umættet uronsyre fra glycosaminoglycaner
NO890700L (no) Fremgangsmaate og system til overvaaking av veggtykkelse i roerledninger, beholdere m.m. og foeler til bruk ved samme.
DE3479349D1 (en) Process for monitoring ultraviolet sources, and arrangement for carrying out the process
Yangui et al. Calculations on crack growth stage

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees